Skip to content

M.D.D. PHARMA

Active Public limited companyfounded 1989active for 37 yearsAvenue Pasteur 2, 1300 WavreKBO/BCE: BE 0437.759.119 subsidiary of #7 employer in Wavre, Wholesale and retail trade sector

Lifetime

22 annual accounts with figures on one time axis, 34 filings since 1990
peak of €1.8m in 2015
-not published
lowest -€23,754 in 2010
€370,209▼ 55.1%
peak of €3.7m in 2017
€565,871▲ 189%
€11.3m▲ 2.1%
peak of 108.3 FTE in 2025
104.8 FTE▼ 3.2%
Board7 names since 2017
6 directors and 5 others
Owners4 names in the annual accounts
100% and 1 other
Documentsfilings and deeds
25-06-202667 days before the deadline
2026financial year
Turnover from €24.8m to €28.6mResult from €823,861 to €370,2093 directors reappointed 10-07Equity from €195,662 to €565,871Cash from €14,919 to €19,800

Key points

from the 2026 annual accounts

Equity

€565,871 from €3.7m in 2017

Equity fell by 85% in 9 years.

Debts

€11.3m 93% of the balance sheet
Financial debts 47%Suppliers 44%Taxes and wages 9%

Of this, €11.3m falls due within a year.

Staff

114 employees on 31-01-2026
342220241817202527242026

In 2026, 27 employees joined and 24 left. On top of that, 32.4 agency workers worked there on average.

Payment terms

80 days to suppliers
Suppliers
58 to 80
Customers
44 to 43

M.D.D. PHARMA pays its suppliers 22 days later than in 2025. Customers pay 1 day earlier.

Filings

34 annual accounts since 1990
deadline1990200020102020

The last five annual accounts were filed 28 to 67 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 210 companies had the same profile as M.D.D. PHARMA has now. Each dot is one company, two years later.

99.0%
were still trading
0.0%
stopped another way
1.0%
went bankrupt
  • Medium-sized
  • 20 years or older
  • solvency under 10%
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 210 companies, not a prediction for M.D.D. PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Director
Director
Director
Auditor,
and 1 other
  • 100%score equity €43.1m (2026) · annual accounts 31-01-2026
  • consolidatesannual accounts 31-01-2026
Board & ownership

Recent changes

3 directors reappointed , and · General meeting of 17-06-2026 · Gazette deed
New statutory auditor appointed, resigned · acts as permanent representative · General meeting of 18-06-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0437759119
3 directors reappointed, 1 statutory auditor reappointed , , and (statutory auditor) · General meeting of 11-09-2023 · Gazette deed
All 64 events

Comparable companies

same main activity, similar in size and age
Company
M.D.D. PHARMA Wavre €28.6m 3.0% 4.6% 104.8
Pharma Force Ghent €26.6m 3.3% 68.9% 104.5
ORTIS Butgenbach €19.4m 3.1% 37.6% 68.3
APOTHEEK DESSEIN Beernem €35.7m 2.5% 34.1% 61.8
BIOPHARM Kortenberg €10.3m 1.8% 44.7% -
OXYCURE Fernelmont €13.8m 2.0% 21.6% 60.1
Apotheek Antverpia Kontich €65.6m 1.1% 26.2% 172.5
-10%0%10%20%€10m€100m€1bnM.D.D. PHARMAEBIT margin

Grey: the largest companies of the sector (retail trade (NACE 47)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as M.D.D. PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €9.7m and €18m, founded between 1968 and 2003.

Official details

Source: KBO
Status
Active since 06-07-1989Normal situation
Registered office
27 active companies are registered at this addressSource: KBO register, as of 21 November 2026.
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 31-01-2026
Establishment unit
2.044.947.2688500 Kortrijk, since 27-09-1989
Financial year end
31 January
Peppol
Reachable since 10-06-2025
Company details

Annual accounts to 31-01-2026

€12.2m▲ 8.3%
Employeeson 31-01-2026
114▲ 2.7%
Filing
Filed on 25-06-2026, 67 days before the end of the filing period
Financials

Companies linked to M.D.D. PHARMA

Parent and group

Insights on M.D.D. PHARMA

M.D.D. PHARMA has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €565,871 and a net result of €370,209.

Equity has been growing by about 14% per year since 2019. Its solvency ranks better than 17% of 122 sector peers (NACE 47) in financial year 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about M.D.D. PHARMA

What is the company number of M.D.D. PHARMA?
The company number of M.D.D. PHARMA is 0437.759.119. The VAT number is the same number with BE in front: BE 0437.759.119.
Where is M.D.D. PHARMA based?
The registered office is at Avenue Pasteur 2, 1300 Wavre.Company details
What does M.D.D. PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of M.D.D. PHARMA?
M.D.D. PHARMA is a public limited company (NV).
When was M.D.D. PHARMA founded?
M.D.D. PHARMA was founded on 06-07-1989.
Is M.D.D. PHARMA still active?
Yes, M.D.D. PHARMA is an active enterprise in the KBO register.
How many employees does M.D.D. PHARMA have?
M.D.D. PHARMA had an average of 104.8 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
Which joint committee does M.D.D. PHARMA fall under?
In its 31-01-2026 annual accounts, M.D.D. PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of M.D.D. PHARMA?
The turnover of M.D.D. PHARMA was €28.6m in financial year 2026, according to the filed annual accounts.
Is M.D.D. PHARMA profitable?
In financial year 2026, M.D.D. PHARMA made a profit of €370,209.
Where can I find the annual accounts of M.D.D. PHARMA?
M.D.D. PHARMA filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of M.D.D. PHARMA due?
M.D.D. PHARMA must file the annual accounts for financial year 2027 by 31-08-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.